Found: 25
Select item for more details and to access through your institution.
Adenovirus Encoded Adjuvant (AdEnA) anti-CTLA-4, a novel strategy to improve Adenovirus based vaccines against infectious diseases and cancer.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1156714
- By:
- Publication type:
- Article
Adenoviral-based vaccine promotes neoantigen-specific CD8<sup>+</sup> T cell stemness and tumor rejection.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 657, p. 1, doi. 10.1126/scitranslmed.abo7604
- By:
- Publication type:
- Article
Integrity of the Antiviral STING-mediated DNA Sensing in Tumor Cells Is Required to Sustain the Immunotherapeutic Efficacy of Herpes Simplex Oncolytic Virus.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3407, doi. 10.3390/cancers12113407
- By:
- Publication type:
- Article
Isolation of Two Novel Human Anti-CTLA-4 mAbs with Intriguing Biological Properties on Tumor and NK Cells.
- Published in:
- Cancers, 2020, v. 12, n. 8, p. 2204, doi. 10.3390/cancers12082204
- By:
- Publication type:
- Article
A Vaccine Targeting Telomerase Enhances Survival of Dogs Affected by B-cell Lymphoma.
- Published in:
- Molecular Therapy, 2010, v. 18, n. 8, p. 1559, doi. 10.1038/mt.2010.104
- By:
- Publication type:
- Article
Coadministration of Telomerase Genetic Vaccine and a Novel TLR9 Agonist in Nonhuman Primates.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 10, p. 1804, doi. 10.1038/mt.2009.165
- By:
- Publication type:
- Article
The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.
- Published in:
- EMBO Journal, 2002, v. 21, n. 19, p. 5017, doi. 10.1093/emboj/cdf529
- By:
- Publication type:
- Article
Longitudinal transcriptomic and genetic landscape of radiotherapy response in canine melanoma.
- Published in:
- Veterinary & Comparative Oncology, 2019, v. 17, n. 3, p. 308, doi. 10.1111/vco.12473
- By:
- Publication type:
- Article
Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumors.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumors.
- Published in:
- Journal of Translational Medicine, 2012, v. 11, n. 1, p. 1, doi. 10.1186/1479-5876-11-62
- By:
- Publication type:
- Article
Novel Human Anti-PD-L1 mAbs Inhibit Immune-Independent Tumor Cell Growth and PD-L1 Associated Intracellular Signalling.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-49485-3
- By:
- Publication type:
- Article
Low TCR avidity and lack of tumor cell recognition in CD8<sup>+</sup> T cells primed with the CEA-analogue CAP1-6D peptide.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 12, p. 1979, doi. 10.1007/s00262-007-0342-z
- By:
- Publication type:
- Article
Development of a Potency Assay for Nous-209, a Multivalent Neoantigens-Based Genetic Cancer Vaccine.
- Published in:
- Vaccines, 2024, v. 12, n. 3, p. 325, doi. 10.3390/vaccines12030325
- By:
- Publication type:
- Article
VENUS, a Novel Selection Approach to Improve the Accuracy of Neoantigens' Prediction.
- Published in:
- Vaccines, 2021, v. 9, n. 8, p. 880, doi. 10.3390/vaccines9080880
- By:
- Publication type:
- Article
LB10. A Randomized, Double-Blind, Placebo-Controlled Efficacy Trial of a Vaccine to Prevent Chronic Hepatitis C Virus Infection in an at-Risk Population.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S997, doi. 10.1093/ofid/ofz415.2493
- By:
- Publication type:
- Article
Rapid Affinity Maturation of Novel Anti-PD-L1 Antibodies by a Fast Drop of the Antigen Concentration and FACS Selection of Yeast Libraries.
- Published in:
- BioMed Research International, 2019, p. 1, doi. 10.1155/2019/6051870
- By:
- Publication type:
- Article
Chimpanzee adenovirus– and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults.
- Published in:
- Science Translational Medicine, 2015, v. 7, n. 300, p. 1, doi. 10.1126/scitranslmed.aac5745
- By:
- Publication type:
- Article
Efficacy of a virus-vectored vaccine against human and bovine respiratory syncytial virus infections.
- Published in:
- Science Translational Medicine, 2015, v. 7, n. 300, p. 1, doi. 10.1126/scitranslmed.aac5757
- By:
- Publication type:
- Article
Replicative conditioning of Herpes simplex type 1 virus by Survivin promoter, combined to ERBB2 retargeting, improves tumour cell-restricted oncolysis.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-61275-w
- By:
- Publication type:
- Article
Efficient induction of T-cell responses to carcinoembryonic antigen by a heterologous prime-boost regimen using DNA and adenovirus vectors carrying a codon usage optimized cDNA.
- Published in:
- International Journal of Cancer, 2005, v. 117, n. 3, p. 444, doi. 10.1002/ijc.21188
- By:
- Publication type:
- Article
Generation of a Novel Mesothelin-Targeted Oncolytic Herpes Virus and Implemented Strategies for Manufacturing.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 2, p. 477, doi. 10.3390/ijms22020477
- By:
- Publication type:
- Article
Adenoviral vaccine targeting multiple neoantigens as strategy to eradicate large tumors combined with checkpoint blockade.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-10594-2
- By:
- Publication type:
- Article
Evaluation of serum levels of soluble interleukin-2 receptor in patients with chronic lymphoproliferative disorders of T-lymphocytes.
- Published in:
- 1989
- By:
- Publication type:
- journal article
Personalized Cancer Vaccines Go Viral: Viral Vectors in the Era of Personalized Immunotherapy of Cancer.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 23, p. 16591, doi. 10.3390/ijms242316591
- By:
- Publication type:
- Article
Generation of a Retargeted Oncolytic Herpes Virus Encoding Adenosine Deaminase for Tumor Adenosine Clearance.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 24, p. 13521, doi. 10.3390/ijms222413521
- By:
- Publication type:
- Article